Leong, L.; Tan, H.L.; Cua, S.; Yong, K.S.M.; Chen, Q.; Choo, A.
Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer. Int. J. Mol. Sci. 2020, 21, 381.
https://doi.org/10.3390/ijms21020381
AMA Style
Leong L, Tan HL, Cua S, Yong KSM, Chen Q, Choo A.
Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer. International Journal of Molecular Sciences. 2020; 21(2):381.
https://doi.org/10.3390/ijms21020381
Chicago/Turabian Style
Leong, Leonard, Heng Liang Tan, Simeon Cua, Kylie Su Mei Yong, Qingfeng Chen, and Andre Choo.
2020. "Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer" International Journal of Molecular Sciences 21, no. 2: 381.
https://doi.org/10.3390/ijms21020381
APA Style
Leong, L., Tan, H. L., Cua, S., Yong, K. S. M., Chen, Q., & Choo, A.
(2020). Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer. International Journal of Molecular Sciences, 21(2), 381.
https://doi.org/10.3390/ijms21020381